BNXTF
Price
$0.75
Change
-$0.02 (-2.60%)
Updated
Aug 15 closing price
Capitalization
90.14M
SDZNY
Price
$59.32
Change
+$0.71 (+1.21%)
Updated
Aug 15 closing price
Capitalization
25.65B
Interact to see
Advertisement

BNXTF vs SDZNY

Header iconBNXTF vs SDZNY Comparison
Open Charts BNXTF vs SDZNYBanner chart's image
BIONXT SOLUTIONS
Price$0.75
Change-$0.02 (-2.60%)
Volume$157
Capitalization90.14M
Sandoz Group AG
Price$59.32
Change+$0.71 (+1.21%)
Volume$15.09K
Capitalization25.65B
BNXTF vs SDZNY Comparison Chart in %
Loading...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDZNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNXTF vs. SDZNY commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNXTF is a Buy and SDZNY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (BNXTF: $0.75 vs. SDZNY: $59.32)
Brand notoriety: BNXTF and SDZNY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BNXTF: 5% vs. SDZNY: 70%
Market capitalization -- BNXTF: $90.14M vs. SDZNY: $25.65B
BNXTF [@Pharmaceuticals: Generic] is valued at $90.14M. SDZNY’s [@Pharmaceuticals: Generic] market capitalization is $25.65B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNXTF’s FA Score shows that 0 FA rating(s) are green whileSDZNY’s FA Score has 0 green FA rating(s).

  • BNXTF’s FA Score: 0 green, 5 red.
  • SDZNY’s FA Score: 0 green, 5 red.
According to our system of comparison, SDZNY is a better buy in the long-term than BNXTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNXTF’s TA Score shows that 5 TA indicator(s) are bullish while SDZNY’s TA Score has 4 bullish TA indicator(s).

  • BNXTF’s TA Score: 5 bullish, 4 bearish.
  • SDZNY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SDZNY is a better buy in the short-term than BNXTF.

Price Growth

BNXTF (@Pharmaceuticals: Generic) experienced а +22.09% price change this week, while SDZNY (@Pharmaceuticals: Generic) price change was +0.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SDZNY($25.7B) has a higher market cap than BNXTF($90.1M). BNXTF YTD gains are higher at: 196.229 vs. SDZNY (48.967). SDZNY has more cash in the bank: 688M vs. BNXTF (80.1K). BNXTF has less debt than SDZNY: BNXTF (5.61M) vs SDZNY (4.85B).
BNXTFSDZNYBNXTF / SDZNY
Capitalization90.1M25.7B0%
EBITDA-5.38MN/A-
Gain YTD196.22948.967401%
P/E RatioN/A114.08-
Revenue42KN/A-
Total Cash80.1K688M0%
Total Debt5.61M4.85B0%
TECHNICAL ANALYSIS
Technical Analysis
BNXTFSDZNY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
35%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
71%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 11 days ago
66%
Bullish Trend 5 days ago
73%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 7 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
25%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDZNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVA4.360.14
+3.32%
Inventiva SA
EC8.910.19
+2.18%
Ecopetrol SA
MARPS4.290.01
+0.15%
Marine Petroleum Trust
ALG222.28-4.14
-1.83%
Alamo Group
CRDL1.31-0.03
-2.24%
Cardiol Therapeutics

BNXTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNXTF has been loosely correlated with DRRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if BNXTF jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
-3.09%
DRRX - BNXTF
62%
Loosely correlated
+0.53%
HLBBF - BNXTF
27%
Poorly correlated
N/A
PAHC - BNXTF
26%
Poorly correlated
+0.33%
SDZXF - BNXTF
24%
Poorly correlated
+2.12%
AMPH - BNXTF
24%
Poorly correlated
-1.26%
More

SDZNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDZNY has been loosely correlated with SDZXF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SDZNY jumps, then SDZXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZNY
1D Price
Change %
SDZNY100%
+1.21%
SDZXF - SDZNY
49%
Loosely correlated
+2.12%
CPHRF - SDZNY
24%
Poorly correlated
-1.06%
RDHL - SDZNY
21%
Poorly correlated
-3.55%
CBSTF - SDZNY
11%
Poorly correlated
-12.70%
BNXTF - SDZNY
8%
Poorly correlated
-3.09%
More